Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
Article in Nature Cancer (January 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Combination of multiple omics techniques for a personalized therapy or treatment selection
Article in Frontiers in Immunology (September 2023)
Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research
Article in Animal Models and Experimental Medicine (September 2023)